Bruker has launched the MyGenius PRO molecular diagnostics system in Europe, offering fully automated, high-throughput PCR testing for infectious diseases with an initial focus on CMV, EBV, and BKV assays for clinical labs.
The rapid RT-PCR assay runs on the FINDER platform, establishing it as a molecular point-of-care platform with multifunctional capabilities.
Utah State researchers have identified new CRISPR-Cas12a3 functions that selectively target pathogen RNA without harming host DNA, potentially enabling a single diagnostic test for COVID-19, flu, and RSVV..
A field-deployable test demonstrates high sensitivity in identifying low-level infections that traditional methods miss, potentially supporting elimination efforts.
University Hospital Southampton is trialing a point-of-care biosensor test for flu, COVID-19, and RSV, delivering results in four minutes, according to the hospital.
The PCR test detects 11 bacterial, viral, and parasitic pathogens from a stool sample in approximately 74 minutes.
Nexus Medical Labs will implement Lybe Scientific’s NAxtra nucleic acid extraction kit in a 60,000-plus test unit deal to enhance high-throughput STI testing, citing improved detection limits and workflow efficiency.